TOKYO -- A noted Japanese stem cell researcher has asked Fujifilm Holdings to keep fees in check for using patented technology related to induced pluripotent stem cells, he told The Nikkei on Wednesday.
Shinya Yamanaka, director of the Center for iPS Cell Research and Application at Kyoto University, intends to negotiate with Fujifilm. Yamanaka -- who won the Nobel Prize in physiology or medicine in 2012 for his work on iPS cells -- sees the relevant patents as crucial to the field of regenerative medicine and fears that steep licensing fees will hinder progress. Attention will now be on how the Tokyo-based company responds.
